PL423168A1 - Zastosowanie markerów biochemicznych do diagnozowania porodu przedwczesnego - Google Patents

Zastosowanie markerów biochemicznych do diagnozowania porodu przedwczesnego

Info

Publication number
PL423168A1
PL423168A1 PL423168A PL42316817A PL423168A1 PL 423168 A1 PL423168 A1 PL 423168A1 PL 423168 A PL423168 A PL 423168A PL 42316817 A PL42316817 A PL 42316817A PL 423168 A1 PL423168 A1 PL 423168A1
Authority
PL
Poland
Prior art keywords
mip
biochemical markers
application
diagnosing
premature birth
Prior art date
Application number
PL423168A
Other languages
English (en)
Other versions
PL237304B1 (pl
Inventor
Grzegorz Raba
Original Assignee
Grzegorz Raba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grzegorz Raba filed Critical Grzegorz Raba
Priority to PL423168A priority Critical patent/PL237304B1/pl
Publication of PL423168A1 publication Critical patent/PL423168A1/pl
Publication of PL237304B1 publication Critical patent/PL237304B1/pl

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Zgłoszenie dotyczy zastosowania markerów biochemicznych BLC, IGFBP-1, BDNF, MIP-1d, ICAM-1, MIP-3b oraz VCAM-1 do diagnozowania porodu przedwczesnego u kobiety ciężarnej z objawami zagrażającego porodu przedwczesnego, które obejmuje określenia kolejno stężeń w surowicy krwi biomarkeru BLC, a następnie stężeń jednego lub więcej z biomarkerów IGFBP-1, BDNF, MIP-1d, ICAM-1, MIP-3b oraz VCAM-1.
PL423168A 2017-10-16 2017-10-16 Zastosowanie markerów biochemicznych do diagnozowania porodu przedwczesnego PL237304B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL423168A PL237304B1 (pl) 2017-10-16 2017-10-16 Zastosowanie markerów biochemicznych do diagnozowania porodu przedwczesnego

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL423168A PL237304B1 (pl) 2017-10-16 2017-10-16 Zastosowanie markerów biochemicznych do diagnozowania porodu przedwczesnego

Publications (2)

Publication Number Publication Date
PL423168A1 true PL423168A1 (pl) 2019-04-23
PL237304B1 PL237304B1 (pl) 2021-04-06

Family

ID=66167868

Family Applications (1)

Application Number Title Priority Date Filing Date
PL423168A PL237304B1 (pl) 2017-10-16 2017-10-16 Zastosowanie markerów biochemicznych do diagnozowania porodu przedwczesnego

Country Status (1)

Country Link
PL (1) PL237304B1 (pl)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL408305A1 (pl) * 2014-05-23 2015-12-07 Uniwersytet Medyczny W Białymstoku Zastosowanie ceramidu C16 (C16-Cer) jako biomarkera w predykcji porodu przedwczesnego

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL408305A1 (pl) * 2014-05-23 2015-12-07 Uniwersytet Medyczny W Białymstoku Zastosowanie ceramidu C16 (C16-Cer) jako biomarkera w predykcji porodu przedwczesnego

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LAUDANSKI P, ASSESSMENT OF THE SELECTED BIOCHEMICAL MARKERS IN PREDICTING PRETERM LABOUR. J MATERN FETAL NEONATAL MED. 2012, December 2012 (2012-12-01) *
LAUDANSKI P, CHEMOKINES PROFILING OF PATIENTS WITH PRETERM BIRTH, 2014 *

Also Published As

Publication number Publication date
PL237304B1 (pl) 2021-04-06

Similar Documents

Publication Publication Date Title
BR112017004773A2 (pt) biomarcadores para avaliar câncer de mama
MX2018012580A (es) Métodos y kits para el diagnóstico y la estratificación de riesgo en pacientes con isquemia.
EP3182126A3 (en) Biomarker test for prediction or early detection of preeclampsia and/or hellp syndrome
EA201290311A1 (ru) Факторы риска и прогнозирование инфаркта миокарда
GB2556004A (en) Markers of stroke and stroke severity
EP3751283A3 (en) Blood-based screen for detecting neurological diseases in primary care settings
WO2016198833A3 (en) Methods for analysing a urine sample
MX2020002788A (es) Biomarcadores de preeclampsia y sistemas y metodos relacionados.
EP3679856A4 (en) CHROMATOGRAPHIC STRIP INCLUDING MULTIPLE TEST LINES, DIAGNOSIS KIT INCLUDING THE SAME, AND QUALITATIVE, SEMI-QUANTITATIVE OR QUANTITATIVE ANALYSIS PROCESS INCLUDING MULTIPLE STEPS OF COMPETITIVE REACTION MEASUREMENT
BR112022011676A2 (pt) Kit para detectar um analito de interesse em uma pluralidade de amostras líquidas biológicas, método para detectá-lo e /ou quantificá-lo e cartucho para realizar tal método
WO2015136509A3 (en) Diagnostic and therapeutic targets for preeclampsia and closely related complications of pregnancy
Leung et al. Ovarian cancer biomarkers: current state and future implications from high-throughput technologies
BR112014031958A2 (pt) bag3 como marcador de tecido e soro bioquímico
BR112018073214A2 (pt) métodos para a previsão do risco de recorrência da fibrilação atrial, para o diagnóstico de fibrilação atrial em um indivíduo, para o monitoramento de uma terapia e para a classificação da fibrilação e utilizações do biomarcador
BR112016023170A2 (pt) biomarcadores para avaliação de hiv
WO2015054700A3 (en) Biomarkers for predicting risk of acute ischemic stroke and methods of use thereof
MX2019000591A (es) Tira mejorada de ensayo de analisis de orina de bajo volumen de muestra, kits analiticos y metodos de uso relacionados con la misma.
BR112018075223A2 (pt) assinaturas de biomarcador de lúpus eritematoso sistêmico e usos das mesmas
BR112018015532A2 (pt) métodos para o diagnóstico de pré-eclâmpsia, para avaliar a gravidade da pré-eclâmpsia, e para o monitoramento pré-eclâmpsia, usos de biomarcador, kit adaptado para a realização do método e dispositivo adaptado para diagnosticar se uma paciente sofre de pré-eclâmpsia
EP4328324A3 (en) Methods of diagnosing epilepsy
Pouwels et al. Srage as biomarker for COPD, introducing novel LC-MS-based methods for the quantification of serum srage levels
Kinsey et al. Radiomics Evaluation of" Aggressive" Solid Lung Cancers from the National Lung Screening Trial
UA109433U (uk) Спосіб діагностики розвитку остеопорозу
PL439313A1 (pl) Sposób określenia ryzyka raków u kobiet w zależności od stężenia arsenu we krwi
UA111397U (uk) Спосіб діагностики розвитку остеопорозу